![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | (2006.01) |
A61K 9/0019 | (2013.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 38/17 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
A61K 38/1709 | (2013.01) | ||
C07K 14/4703 | (2013.01) | ||
C07K 14/47 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
C07K 14/4705 | (2013.01) | ||
A61P 43/00 | (2006.01) | ||
C07K 14/705 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
C07K 14/7155 | (2013.01) | ||
C07K 14/715 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 37/04 | (2006.01) | ||
A61P 37/04 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 39/001122 | (2018.08) | ||
A61K 39/00115 | (2018.08) | ||
A61K 39/001119 | (2018.08) | ||
A61K 39/001192 | (2018.08) | ||
A61K 39/001153 | (2018.08) |
(11) | Number of the document | 3511013 |
(13) | Kind of document | T |
(96) | European patent application number | 18211075.9 |
Date of filing the European patent application | 2011-08-23 | |
(97) | Date of publication of the European application | 2019-07-17 |
(45) | Date of publication and mention of the grant of the patent | 2022-09-07 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
37658210 P | 2010-08-24 | US |
(72) |
Okada, Hideho , US
|
(73) |
University of Pittsburgh - Of the Commonwealth
System of Higher Education ,
1st Floor Gardner Steel Conference Center
130 Thackeray Avenue, Pittsburgh, PA 15260,
US
|
(54) | INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES |
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES |